Radiotherapy of malignant gliomas: Results from conventional treatment methods and the prospects of advanced techniques;La radioterapia dei gliomi maligni. I risultati delle modalità tradizionali di trattamento e le prospettive delle tecniche avanzate

Radiologia Medica

Volumn 107, Issue 1-2, 2004, Pages 128-135

  Rubino, Giovanni ^a   Sacco, Palmino ^a   Cerase, Alfonso ^a   Volterrani, Luca ^a   Sebaste, Lucio ^a   Pepi, Fiorella ^a   Pirtoli, Luigi ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Computed Tomography (CT); Conformal Radiotherapy; Image Fusion; Magnetic Resonance (MR); Malignant gliomas; Radiotherapy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1542510795     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. World Health Organization Classification of Tumors. Pathology and genetics. Tumors of the nervous system. 2000.
2. International Commission on Radiation Units and Measurements. Report 50. Prescribing, recording and reporting photon beam therapy. ICRU Publications, Bethesda, 1993.
3. International Commission on Radiation Units and Measurements. Report 62. Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50). ICRU Publications, Bethesda, 1999.
4. Hamilton RJ, Sweeney PJ, Pelizzari CA et al: Functional imaging in treatment planning of brain lesions. Int J Radiat Oncol Biol Phys 37: 181-188, 1997.
5. Pirzkall A, McKnight TR, Graves EE et al: MR-spectroscopy guided target delineation for high grade gliomas. Int J Radiat Oncol Biol Phys 50: 915-928, 2001.
6. Gross MW, Weber WA, Feldman HJ et al: The value of F-18-Fluorodeoxiglucose PET for the 3D radiation treatment planning of malignant gliomas. Int J Radiat Oncol Biol Phys 41: 989-995, 1998.
7. Grosu AL, We W, Feldman HJ et al: First experience with I-123-alpha-methyltyrosine SPECT in the 3D radiation treatment planning of brain gliomas. Int J Radiat Oncol Biol Phys 47: 517-526, 2000.
8. Gerweck LE, Kornblith PL, Burlett P et al: Radiation sensitivity of cultured human glioblastoma cells. Radiology 125: 231-234, 1977.
9. Budach W, Gioioso D, Taghian A et al: Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro. Int J Radiat Oncol Biol Phys 39: 743-750, 1997.
10. Hochberg FH, Pruitt A: Assumption in the radiotherapy of glioblastoma. Neurology 30: 907-911, 1980.
11. Burger PC, Dubois PJ, Schold SC et al: Computerized tomographic and pathologic studies of the untreated, quiescent and recurrent glioblastoma multiforme. J Neurosurg 58: 159-169, 1983.
12. Wallner KE, Galicich JH, Krol G et al: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int. J Radiat Oncol Biol Phys 16: 1405-1409, 1989.
13. Garden AS, Maor MH, Yung WKA et al: Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 20: 99-110, 1991.
14. Lee SW, Fraass BA, Marsh LH et al: Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 43: 79-88, 1998.
15. Morris DE, Bourland JD, Rosenman JG et al: Three-dimensional conformal radiation treatment plyearsng and delivery for low- and intermediate grade gliomas. Sem Radiat Oncol 11: 124-137, 2001.
16. Matsusani M, Nakamura O, Nagashima T et al: Intraoperative radiation therapy for malignant brain tumors: rationale, methods and treatment results of cerebral glioblastomas. Acta Neurochir 131: 80-90, 1994.
17. Ortiz de Urbina D, Santos M, Garcia-Berrocal I et al: Intraoperative radiation therapy in malignant glioma: early clinical results. Neurol Res 17: 289-294, 1995.
18. Castro J, Phillips T, Prados M et al: Neon heavy charged particle radiotherapy of glioblastoma of the brain. Int J Radiat Oncol Biol Phys 38: 257-261, 1997.
19. Pickles T, Goodman GB, Rheaume D et al: Pion radiation for high-grade astrocytoma. Results of a randomized study. Int J Radiat Oncol Biol Phys 37: 491-497, 1997.
20. Gannet D, Stea B, Lulu B et al: Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Int J Radiat Oncol Biol Phys 33: 461-468, 1995.
21. Sarkaria JN, Mehta MP, Loeffler JS et al: Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Int J Radiat Oncol Biol Phys 32: 931-941, 1995.
22. Nakagawa K, Aoki Y, Fujimaki T et al: High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40: 1141-1149, 1998.
23. Cho KH, Hall WA, Gerbi BJ et al: Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int. J Radiat Oncol Biol Phys 45: 1133-1141, 1999.
24. Laperriere NJ, Leung PMK, Mc Kenzie S et al: Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41: 1005-1011, 1998.
25. Videtic GMM, Gaspar LE, Zamorano L et al: Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Radiat Oncol Biol Phys 45: 687-692, 1999.
26. Micke O, Schäfer U, Prott FJ et al: High dose rate brachytherapy in malignant brain tumors. J Brachytherapy Int 16: 63-72, 2000.
27. Deutsch M, Green SB, Strike TA et al: Results of a randomized trial comparing BCNU plus radiotherapy, streptozocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 16: 1389-1396, 1989.
28. Furst-Nelson D, Curran WJ, Scott C et al: Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma - possible advantage observed at 72.0 Gy in 1.2 Gy BID fractions: report of the Radiation Therapy Oncology Group protocol 8302. Int J Radiat Oncol Biol Phys 25: 193-207, 1993.
29. Buatti JM, Marcus RB, Mendenhall WM et al: Accelerated hyperfractionated radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 34: 785-792, 1996.
30. Botturi M, Fariselli L: Clinical results of unconventional fractionation radiotherapy in central nervous system tumors. Tumori 84: 176-187, 1998.
31. Genc M, Zorlu AF, Atahan IL: Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas. Radiother Oncol 56: 233-238, 2000.
32. Kaplan EL, Meyer P: Non parametric estimation for incomplete observations. J Am Stat Assoc 53: 457-481, 1953.
33. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748, 1959.
34. Walker MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5: 1725-1731, 1979.
35. Miller PJ, Hassanein RS, Shankar Giri PG et al: Univariate and multivariate statistical analysis of high-grade gliomas: the relationship of radiation dose and other prognostic factors. Int J Radiat Oncol Biol Phys 19: 275-280, 1990.
36. Curran WJ, Scott CB, Horton J et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85: 704-710, 1993.
37. Shapiro WR, Green SB, Burger PC: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma: BTCG trial 8001. J Neurosurg 71: 1-9, 1989.
38. Urtasun RC, Cosmatos D, Delrowe J et al: Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12). Int J Radiat Oncol Biol Phys 27: 207-214, 1993.
39. Thornton AF, Sandler HM, Haken RK et al: The clinical utility of magnetic resonance imaging in 3-Dimensional treatment planning of brain neoplasm. Int J Radiat Oncol Biol Phys 24: 767-775, 1992.
40. Salazar OM, Rubin P, Feldstein R et al: High dose radiation therapy in the treatment of malignant gliomas: final report. Int J Radiat Oncol Biol Phys 5: 1733-1740, 1979.
41. Haas-Kogan DA, Yount G, Haas M et al: p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiological response of glioblastoma. Int J Radiat Oncol Biol Phys 36: 95-103; 1996.
42. Barker FG, Simmons ML, Chang SM et al: EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 51: 410-418, 2001.